Toledo, Ohio-based ProMedica recorded an operating income of $249.4 million (8.1% operating margin) in 2025, up from $147.6 million (5% margin) in 2024, according to its Feb. 27 financial report.
The system reported total revenue of $3.1 billion for the 12 months ended Dec. 31, up from $2.9 billion in 2024. Net patient revenue was $2.8 billion, up from $2.7 billion.
Total operating expenses were $2.7 billion in 2025, up from $2.6 billion in 2024. Salaries, wages and benefits totaled $1.4 billion, up from $1.3 billion. Supply expenses were $298.1 million, up from $286 million.
ProMedica President and CEO Arturo Polizzi told Becker’s in December that when he stepped into the role in 2022, the system put together a turnaround plan, underwent corporate restructuring and divested from several noncore business lines.
In 2022, the system divested from 147 skilled nursing facilities that were responsible for a more than $200 million operating loss that year. In 2023, ProMedica sold its national hospice business and in 2024 it sold its insurance business to Cleveland-based Medical Mutual of Ohio. More recently, ProMedica spun off 47 assisted living facilities into a separate organization, relieving the system of more than $350 million in lease obligations.
Mr. Polizzi said those four moves “are really what put us in a good position to get lean and mean and profitable.”
ProMedica reported a net income of $260.8 million in 2025, up from $110.3 million in 2024.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
